Shares of Health Care sector company AbbVie moved -1.2% today, and are now trading at a price of $140.13. The large-cap stock's daily volume was 4,532,796 compared to its average volume of 4,302,773. The S&P 500 index returned a 1.0% performance.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company is based in North Chicago and has 50,000 full time employees. Its market capitalization is $247,345,266,688. AbbVie currently offers its equity investors a dividend that yields 4.2% per year.
24 analysts are following AbbVie and have set target prices ranging from $127.32 to $193.34 per share. On average, they have given the company a rating of buy. At today's prices, ABBV is trading -12.53% away from its average analyst target price of $160.21 per share.
Over the last year, ABBV shares have gone down by -4.0%, which represents a difference of -14.0% when compared to the S&P 500. The stock's 52 week high is $168.11 per share and its 52 week low is $130.96. With average free cash flows of $18.9 Billion that have been growing at an average rate of 11.7% over the last 6 years, AbbVie declining stock performance may not be reflective of the quality of its underlying business.
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
---|---|---|---|---|
2023 | 25,542,000 | 743,000 | 24,799,000 | 2.27 |
2022 | 24,943,000 | 695,000 | 24,248,000 | 10.27 |
2021 | 22,777,000 | 787,000 | 21,990,000 | 30.97 |
2020 | 17,588,000 | 798,000 | 16,790,000 | 31.46 |
2019 | 13,324,000 | 552,000 | 12,772,000 | -0.13 |
2018 | 13,427,000 | 638,000 | 12,789,000 |